The funding will support a Phase 1b/2a clinical trial of inhaled murepavadin, an antibiotic that targets multi-drug resistant Pseudomonas aeruginosa….
Philanthropy News Digest | https://philanthropynewsdigest.org/rss/feed/pndnewsThe funding will support a Phase 1b/2a clinical trial of inhaled murepavadin, an antibiotic that targets multi-drug resistant Pseudomonas aeruginosa….
Philanthropy News Digest | https://philanthropynewsdigest.org/rss/feed/pndnews